La Trobe

Presence and characteristics of disordered eating and orthorexia in irritable bowel syndrome

Download (1.72 MB)
journal contribution
posted on 2024-07-30, 01:29 authored by Nessmah SultanNessmah Sultan, Mandy FoysterMandy Foyster, Matilda Tonkovic, Danielle Noon, Helen Burton-Murray, Jessica BiesiekierskiJessica Biesiekierski, Caroline TuckCaroline Tuck
Introduction: Orthorexia, a harmful obsession with eating healthily, may develop from illnesses characterized by dietary restriction, including irritable bowel syndrome (IBS) and eating disorders (ED). Evidence of disordered eating in IBS exists, but orthorexia has not been assessed. This cross-sectional study in adults (≥18 years) assessed presence and characteristics of disordered eating and orthorexia in IBS, compared to control subjects (CS) and ED. Methods: IBS participants met Rome IV, and ED participants met DSM-5 criteria. Disordered eating was assessed using “sick, control, one-stone, fat, food” (SCOFF, ≥2 indicating disordered eating), and orthorexia by the eating habits questionnaire (EHQ). Secondary measures included stress (PSS); anxiety (HADS-A); food-related quality of life (Fr-QoL), and dietary intake (CNAQ). Key Results: In 202 IBS (192 female), 34 ED (34 female), and 109 CS (90 female), more IBS (33%) and ED (47%) scored SCOFF≥2 compared to CS (16%, p < 0.001, chi-square). IBS and ED had higher orthorexia symptom severity compared to CS (EHQ IBS 82.9 ± 18.1, ED 90.1 ± 19.6, and CS 73.5 ± 16.9, p < 0.001, one-way ANOVA). IBS and ED did not differ for SCOFF or EHQ (p > 0.05). Those with IBS and disordered eating had higher orthorexia symptom severity (EHQ 78.2 ± 16.6 vs. 92.4 ± 17.5, p < 0.001, independent t-test), worse symptoms (IBS-SSS 211.0 ± 78.4 vs. 244.4 ± 62.5, p = 0.008, Mann–Whitney U test), higher stress (p < 0.001, independent t-test), higher anxiety (p = 0.002, independent t-test), and worse FR-QoL (p < 0.001, independent t-test). Conclusions and Inferences: Disordered eating and orthorexia symptoms occur frequently in IBS, particularly in those with worse gastrointestinal symptoms, higher stress, and anxiety. Clinicians could consider these characteristics when prescribing dietary therapies.

Funding

Project supported by La Trobe University Seed Funding awarded to JRB. This manuscript was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (HBM, K23DK131334).

History

Publication Date

2024-07-01

Journal

Neurogastroenterology & Motility

Volume

36

Issue

7

Article Number

e14797

Pagination

12p.

Publisher

Wiley

ISSN

1350-1925

Rights Statement

© 2024 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Usage metrics

    Journal Articles

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC